Back
Keros Therapeutics Stock Price Chart
![](/images/offers/ims/large/offer13.jpg)
Nvidia's march to $5 trillion
Click here to see how Nvidia's march to $5 trillion could impact its partners.
Sell
27
KROS
Keros Therapeutics
Last Price:
45.71
Seasonality Move:
4.22%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer12.jpg)
A massive $1 Trillion AI superproject is underway
Click here to discover these key companies behind this $1 trillion Superproject- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight buying pressure.
Keros Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 45.61 | Buy |
20-day SMA: | 47.29 | Sell |
50-day SMA: | 51.65 | Sell |
200-day SMA: | 47.07 | Sell |
8-day EMA: | 45.93 | Sell |
20-day EMA: | 47.34 | Sell |
50-day EMA: | 50.89 | Sell |
200-day EMA: | 50 | Sell |
Keros Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.79 | Sell |
Relative Strength Index (14 RSI): | 38.41 | Sell |
Chaikin Money Flow: | 239305 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (45.72 - 49.1) | Sell |
Bollinger Bands (100): | (49.87 - 64.91) | Sell |
Keros Therapeutics Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Keros Therapeutics Stock
Is Keros Therapeutics Stock a Buy?
- Keros Therapeutics share price is 45.70 while KROS 8-day simple moving average is 45.61, which is a Buy signal.
- The stock price of KROS is 45.70 while Keros Therapeutics 20-day SMA is 47.29, which makes it a Sell.
- Keros Therapeutics 50-day simple moving average is 51.65 while KROS share price is 45.70, making it a Sell technically.
- KROS stock price is 45.70 and Keros Therapeutics 200-day simple moving average is 47.07, creating a Sell signal.
KROS Technical Analysis vs Fundamental Analysis
Sell
27
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy or a Sell?
-
Keros Therapeutics stock is rated a Sell
The current Keros Therapeutics [KROS] share price is $45.70. The Score for KROS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
Keros Therapeutics Stock Info
Market Cap:
1.65B
Price in USD:
45.70
Share Volume:
584.35K
Keros Therapeutics 52-Week Range
52-Week High:
73.00
52-Week Low:
27.02
Sell
27
Keros Therapeutics (KROS)
is a Sell
Keros Therapeutics Share Price Forecast
-
What is the Keros Therapeutics stock price today?
The Keros Therapeutics stock price is 45.70 USD today. -
Will KROS stock go up or go down?
Keros Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Keros Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Keros Therapeutics is overvalued.
Is Keros Therapeutics Stock a Buy?
- Keros Therapeutics share price is 45.70 while KROS 8-day exponential moving average is 45.93, which is a Sell signal.
- The stock price of KROS is 45.70 while Keros Therapeutics 20-day EMA is 47.34, which makes it a Sell.
- Keros Therapeutics 50-day exponential moving average is 50.89 while KROS share price is 45.70, making it a Sell technically.
- KROS stock price is 45.70 and Keros Therapeutics 200-day simple moving average is 50.00, creating a Sell signal.
Fundamental Analysis of Keros Therapeutics
Is Keros Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.
Technical Analysis of Keros Therapeutics
Should I short Keros Therapeutics stock?
- KROS Moving Average Covergence Divergence (MACD) indicator is -1.79, suggesting Keros Therapeutics is a Sell
- Keros Therapeutics Relative Strength Index (RSI) is 38.41, which suggest Keros Therapeutics is oversold
- The Bollinger Bands (25) for Keros Therapeutics is (45.72 - 49.1), which suggest Keros Therapeutics is a Sell
- The Bollinger Bands (100) for Keros Therapeutics is (49.87 - 64.91), which suggest Keros Therapeutics is a Sell
* Keros Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.